There is emerging evidence for a genetic basis of patient-reported quality-of-life (QOL) outcomes that can ultimately be incorporated into clinical research and practice. Objectives are (1) to provide arguments for the timeliness of investigating the genetic basis of QOL given the scientific advances in genetics and patient-reported QOL research; (2) to describe the clinical implications of such investigations; (3) to present a theoretical foundation for investigating the genetic underpinnings of QOL; and (4) to describe a series of papers resulting from the GENEQOL Consortium that was established to move this work forward.
Discussion of scientific advances based on relevant literature.
In genetics, technological advances allow for increases in speed and efficiency and decreases in costs in exploring the genetic underpinnings of disease processes, drug metabolism, treatment response, and survival. In patient-based research, advances yield empirically based and stringent approaches to measurement that are scientifically robust. Insights into the genetic basis of QOL will ultimately allow early identification of patients susceptible to QOL deficits and to target care. The Wilson and Cleary model for patient-reported outcomes was refined by incorporating the genetic underpinnings of QOL.
This series of papers provides a path for QOL and genetics researchers to work together to move this field forward and to unravel the intricate interplay of the genetic underpinnings of patient-reported QOL outcomes. The ultimate result will be a greater understanding of the process relating disease, patient, and doctor that will have the potential to lead to improved survival, QOL, and health services delivery.
Pluzhnikov, A., Below, J. E., Konkashbaev, A., Tikhomirov, A., Kistner-Griffin, E., Roe, C. A., et al. (2010). Spoiling the whole bunch: Quality control aimed at preserving the integrity of high-throughput genotyping. The American Journal of Human Genetics, 87, 123–128. CrossRef
Fayers, P. M., Hopwood, P., Harvey, A., Girling, D. J., Machin, D., & Stephens, R. (1997). Quality of life assessment in clinical trials—guidelines and a checklist for protocol writers: The UK Medical Research Council experience. MRC Cancer Trials Office. European Journal of Cancer, 33, 20–28. CrossRefPubMed
Efficace, F., Bottomley, A., Osoba, D., Gotay, C., Flechtner, H., D’haese, S., et al. (2003). Beyond the development of health-related quality of life (HRQOL) measures. A checklist for evaluating HRQOL outcomes in cancer clinical trials—does HRQOL evaluation in prostate cancer research inform clinical decision-making? Journal of Clinical Oncology, 21, 3502–3511. CrossRefPubMed
Singh, J. A., Nelson, D. B., Fink, H. A., & Nichol, K. L. (2005). Health-related quality of life predicts future health-care utilization and mortality in veterans with self-reported physician-diagnosed arthritis: The veterans arthritis quality of life study. Seminars in Arthritis Rheumatism, 34, 755–765. CrossRefPubMed
Svedberg, P., Gatz, M., Lichtenstein, P., Sandin, S., & Pedersen, N. L. (2005). Self-rated health in a longitudinal perspective: A 9-year follow-up twin study. Journal of Gerontology Series B: Psychological Sciences and Social Sciences, 60, S331–S340.
Yang, P., Mandrekar, S. J., Hillman, S. H., Allen Ziegler, K. L., Sun, Z., Wampfler, J. A., et al. (2009). Evaluation of glutathione metabolic genes on outcomes in advanced non-small cell lung cancer patients after initial treatment with platinum-based chemotherapy: An NCCTG-97-24-51 based study. Journal of Thoracic Oncology, 4, 479–485. CrossRefPubMed
Janssens, A. C., & Van Duijn, C. M. (2009). Genome-based prediction of common diseases: Methodological considerations for future research. Genome Medicine, 18, 20. CrossRef
de la Fuente-Fernandez, R. (2009). The placebo-reward hypothesis: Dopamine and the placebo effect. Parkinsonism and Related Disorders, 15S3, S72–S74. CrossRef
Higgins, E. S. (2009). The new genetics of mental illness. Scientific American Mind, 19, 41–47.
Sprangers, M. A. G., Sloan, J. A., Veenhoven, R., Cleeland, C. S., Halyard, M. Y., Abernethy, A. P., et al. (2009). The establishment of the GENEQOL Consortium to investigate the genetic disposition of patient-reported quality-of-life outcomes. Twin Research Human Genetics, 12, 301–311. CrossRef
Chauhan, C. I am the quintessential optimist, I think that I have the quality-of-life gene in spades: reflections from a patient perspective (Commentary). Quality of Life Research, Epub ahead of print.
Shi, Q., Cleeland, C., Miaskowski, C., Klepstad, P., Pedersen, N., & The GENEQOL Consortium. Biological pathways and genetic variables involved in pain. Quality of Life Research, manuscript accepted for publication.
Barsevick, A., Frost, M., Zwinderman, A., Hall, P., Halyard, M. I., & The GENEQOL Consortium. I am so tired: Biological and genetic mechanisms of cancer-related fatigue. Quality of Life Research, manuscript accepted for publication.
Sprangers, M. A. G., Bartels, M., Veenhoven, R., Baas, F., Martin, N., Movsas, B., et al. Which patient will feel down, which will be happy? The need to study the genetic disposition of emotional states. Quality of Life Research, Epub ahead of print.
Raat, H., Van Rossem, L., Jaddoe, V. W. V., Landgraf, J. M., Feeny, D., Hofman, A., & Mackenbach, J. P. Candidate gene study and genome-wide association study on health-related quality of life of mothers and young children: the Generation R study. Quality of Life Research, manuscript accepted for publication.
Plomin, R., DeFries, J. C., McClearn, G. E., & McGuffin, P. (2008). Behavioral genetics (5th ed., pp. 1–532). New York: Worth Publishers and W. H. Freeman and Company.
- Scientific imperatives, clinical implications, and theoretical underpinnings for the investigation of the relationship between genetic variables and patient-reported quality-of-life outcomes
Mirjam A. G. Sprangers
Jeff A. Sloan
Amylou C. Dueck
Cornelis J. F. Van Noorden
The GENEQOL Consortium
- Springer Netherlands